Usefulness of hydralazine to withdraw from dobutamine in severe congestive heart failure
- 15 October 1991
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 68 (10) , 1103-1106
- https://doi.org/10.1016/0002-9149(91)90507-h
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Influence of positive inotropic therapy on pulsatile hydraulic load and ventricular-vascular coupling in congestive heart failureJournal of the American College of Cardiology, 1990
- Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hopeJournal of the American College of Cardiology, 1988
- Correlation between effects of hydralazine on force and on the adenyl cyclase system of ventricular myocardium in dogs and catsCardiovascular Research, 1986
- Hydralazine therapy in chronic congestive heart failureThe American Journal of Medicine, 1984
- Drugs Five Years LaterAnnals of Internal Medicine, 1983
- Positive inotropic effects of hydralazine in human subjects: Comparison with prazosin in the setting of congestive heart failureThe American Journal of Cardiology, 1980
- Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.Circulation, 1978
- The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.Circulation, 1977
- Dobutamine: development of a new catecholamine to selectively increase cardiac contractility.Circulation Research, 1975